Digital Europe 2026: Europe Funds Operational Clinical Pilots of AI in Medical Centers

The opening of the DIGITAL-2026-AI-PILOTING-10-SCREENING The opening of the DIGITAL-2026-AI-PILOTING-10-SCREENING call, with a total budget of €9 million, marks a concrete step in Europe’s strategy for artificial intelligence in healthcare: bringing imaging-based solutions directly into clinical settings, with a focus on early detection of cancer and cardiovascular disease — no longer just research, but operational…

Mammography screening: Swedish study in The Lancet confirms the effectiveness of Artificial Intelligence

The final results of the MASAI study, published in The Lancet and covered by major international media outlets such as The Guardian, mark a turning point in oncological diagnostics. The randomized trial, involving over 100,000 women in Sweden, demonstrates that integrating AI into the screening workflow is not only safe, but superior to traditional methods.…

Breast Cancer Prevention with AI: Health Triage Featured in the New Spin-off of “Artificial Intelligence Explained Simply”

Breast cancer, thanks to the effectiveness of prevention programs, is the most diagnosed cancer worldwide. However, it still remains the leading cause of cancer-related death among women. Artificial Intelligence has already entered the healthcare sector, driven by the expertise and determination of many Italian professionals. This is the focus of “My Health”, the new spin-off…

Prostate cancer diagnosis: Health Triage in Florence for the Tuscan GOM network meeting.

On March 26–27, 2026, Health Triage will participate as a sponsor in the course “Diagnosis, Staging and Multidisciplinary Management of Prostate Cancer: The Tuscan GOM Network in Action.” The event, which will take place at the Grand Hotel Mediterraneo in Florence, represents a strategic opportunity for discussion among coordinators of regional oncology networks, aimed at…

Breast screening and AI: Francesca Caumo (GISMa) explains the value of the Breast AI study in La Repubblica

Artificial Intelligence is entering the core of organized mammographic screening. In La Repubblica, within the Health special section, Dr. Francesca Caumo, Vice President of GISMa (Italian Group for Mammographic Screening), discusses the challenges and opportunities related to integrating new technologies into prevention pathways. At the center is the large prospective multicenter study, Breast AI, born…

Breast screening: partnership between the Italian Mammography Screening Group (GISMa) and Health Triage for one of the most innovative European studies on the use of Artificial Intelligence

An agreement has been signed for a clinical validation study involving 75,000 women: the goal is to strengthen the national prevention programme through “intelligent triage”, which optimises radiologists’ work and accelerates diagnoses. TURIN, 12 February 2026 – With the introduction of new guidelines on AI applied to prevention at the end of 2025, Italy strengthens…

BREAST CANCER SCREENING AND ARTIFICIAL INTELLIGENCE: A TURNING POINT IN THE ITALIAN NATIONAL INSTITUTE OF HEALTH GUIDELINES

The update of the national Guidelines on 23 December 2025 marks a turning point for cancer prevention in Italy. For the first time, the national panel, adopting the GRADE methodology, issued a conditional recommendation in favor of using an AI-based triage strategy for reading mammograms within breast cancer screening programs. Question 3: a strategic innovation…